Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery

Strahlentherapie und Onkologie

Volumn 187, Issue 11, 2011, Pages 715-721

  Heinzelmann, Frank ^a   Thorwarth, Daniela ^a   Lamprecht, Ulf ^a   Kaulich, Theodor W ^a   Fuchs, Jörg ^a   Seitz, Guido ^a   Ebinger, Martin ^a   Handgretinger, Rupert ^a   Bamberg, Michael ^a   Weinmann, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bladder prostate rhabdomyosarcoma; Brachytherapy; Childhood; Intensity modulated proton therapy; Intensity modulated radiotherapy

Indexed keywords

DACTINOMYCIN; IFOSFAMIDE; VINCRISTINE;

ARTICLE; BLADDER RHABDOMYOSARCOMA; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHILD; COMBINATION CHEMOTHERAPY; CYSTECTOMY; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; INTENSITY MODULATED PROTON THERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; MULTIPLE CYCLE TREATMENT; PELVIS; PRESCHOOL CHILD; PROSTATE RHABDOMYOSARCOMA; PROSTATECTOMY; PROTON THERAPY; RADIATION DOSE; RECTUM; RHABDOMYOSARCOMA; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTECTOMY; HUMANS; INFANT; MALE; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; ORGANS AT RISK; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RHABDOMYOSARCOMA, EMBRYONAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84856212008     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2261-3     Document Type: Article

References (47)

1. Arndt C, Rodeberg D, Breitfeld PP et al. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv. J Urol 2004;171:2396-403. (Pubitemid 38625499)
2. Bolling T, Schuck A, Pape H et al. German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results. Strahlenther Onkol 2007;183:7-8.
3. Bolling T, Schuck A, Rube C et al. [Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study]. Strahlenther Onkol 2006;182:443-9. (Pubitemid 44214487)
4. Castillo LA, Craft AW, Kernahan J et al. Gonadal function after 12-Gy testicular irradiation in childhood acute lymphoblastic leukaemia. Med Pediatr Oncol 1990;18:185-9. (Pubitemid 20150570)
5. Centola GM, Keller JW, Henzler M et al. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl 1994;15:608-13.
6. Clifton DK, Bremner WJ. The effect of testicular X-irradiation on spermatogenesis in man. A comparison with the mouse. J Androl 1983;4:387-92.
7. Cotter SE, Herrup DA, Friedmann A et al. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2010 Oct 7 [Epub ahead of print].
8. Donaldson SS, Meza J, Breneman JC et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma - A report from the IRSG. Int J Radiat Oncol Biol Phys 2001;51:718-28.
9. Dorr W, Herrmann T. Second tumors after oncologic treatment. Strahlenther Onkol 2008;184:67-72. (Pubitemid 351231656)
10. Eifel PJ, Donaldson SS, Thomas PR. Response of growing bone to irradiation: a proposed late effects scoring system. Int J Radiat Oncol Biol Phys 1995;31:1301-7.
11. Ferrer FA. Re: Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from Intergroup Rhabdomyosarcoma Study IV. J Urol 2004;172:2084. (Pubitemid 39363136)
12. Ferrer FA, Isakoff M, Koyle MA. Bladder/prostate rhabdomyosarcoma: past, present and future. J Urol 2006;176:1283-91. (Pubitemid 44307206)
13. Gonzalez DG, van Dijk JD. Experimental studies on the response of growing bones to X ray and neutron irradiation. Int J Radiat Oncol Biol Phys 1983;9:671-7. (Pubitemid 13106631)
14. Haie-Meder C, Breton-Callu C, Oberlin O et al. [Brachytherapy in the treatment of vesicoprostatic rhabdomyosarcomas in children]. Cancer Radiother 2000;4:145s-9s. (Pubitemid 32012707)
15. Hahn EW, Feingold SM, Nisce L. Aspermia and recovery of spermatogenesis in cancer patients following incidental gonadal irradiation during treatment: a progress report. Radiology 1976;119:223-5.
16. Hays DM, Raney RB, Jr., Lawrence W, Jr. et al. Bladder and prostatic tumors in the Intergroup Rhabdomyosarcoma Study (IRS-I): results of therapy. Cancer 1982;50:1472-82. (Pubitemid 12034539)
17. Hays DM, Raney RB, Wharam MD et al. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee. J Pediatr Hematol Oncol 1995;17:46-52.
18. Hermesse J, Biver S, Jansen N, et al. A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy. Strahlenther Onkol 2009;185:736-42.
19. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005:12-7.
20. Kaatsch P, Debling D, Blettner M et al. Second malignant neoplasms after childhood cancer in Germany-results from the long-term follow-up of the German Childhood Cancer Registry. Strahlenther Onkol 2009;185:8-10.
21. Kinsella TJ, Trivette G, Rowland J et al. Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease. J Clin Oncol 1989;7:718-24. (Pubitemid 19145592)
22. Krasin MJ, Constine LS, Friedman DL et al. Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other. Semin Radiat Oncol 2010;20:21-9.
23. Lee CT, Bilton SD, Famiglietti RM et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 2005;63:362-72. (Pubitemid 41628026)
24. Lott S, Lopez-Beltran A, Maclennan GT et al. Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol 2007;38:807-23. (Pubitemid 46726520)
25. Lott S, Lopez-Beltran A, Montironi R et al. Soft tissue tumors of the urinary bladder Part II: malignant neoplasms. Hum Pathol 2007;38:963-77. (Pubitemid 46899159)
26. Martelli H, Haie-Meder C, Branchereau S et al. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience. J Pediatr Surg 2009;44:190-6.
27. McDowell HP. Update on childhood rhabdomyosarcoma. Arch Dis Child 2003;88:354-7. (Pubitemid 36398983)
28. McKenney JK, Amin MB. The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms. Semin Diagn Pathol 2005;22:69-87. (Pubitemid 43163180)
29. Merchant TE. Proton beam therapy in pediatric oncology. Cancer J 2009;15:298-305.
30. Mizumoto M, Sugahara S, Nakayama H, et al. Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther 2010;186:482-8.
31. Muzik J, Soukup M, Alber M. Comparison of fixed-beam IMRT, helical tomotherapy, and IMPT for selected cases. Med Phys 2008;35:1580-1592. (Pubitemid 351457525)
32. Paulino AC, Constine LS, Rubin P et al. Normal tissue development, homeostasis, senescence, and the sensitivity to radiation injury across the age spectrum. Semin Radiat Oncol 2010;20:12-20.
33. Peeters J, Meitert J, Paulides M et al. Late effects surveillance system after childhood cancer in Germany, Austria and parts of Switzerland-update 2009. Strahlenther Onkol 2009;185:5-7.
34. Raney, B, Anderson, J, Jenney, M, et al. Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region: a report from the international workshop. J Urol 2006;176:2190-4; discussion 2194-5. (Pubitemid 44633190)
35. Rowley MJ, Leach DR, Warner GA et al. Effect of graded doses of ionizing radiation on the human testis. Radiat Res 1974;59:665-78.
36. Seitz G, Dantonello TM, Int-Veen C, et al. Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the cooperative soft tissue sarcoma trial CWS-96. Pediatr Blood Cancer 2011;56(5):718-24.
37. Shalet SM. Gonadal function following radiation and cytotoxic chemotherapy in childhood. Ergeb Inn Med Kinderheilkd 1989;58:1-21.
38. Silverman CL, Thomas PR, McAlister WH et al. Slipped femoral capital epiphyses in irradiated children: dose, volume and age relationships. Int J Radiat Oncol Biol Phys 1981;7:1357-63. (Pubitemid 12241700)
39. Sklar CA, Robison LL, Nesbit ME et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol 1990;8:1981-7.
40. Soukup M, Sohn M, Yan D et al. Study of robustness of IMPT and IMRT for prostate cancer against organ movement. Int J Radiat Oncol Biol Phys 2009;75:941-9.
41. Spunt SL, Sweeney TA, Hudson MM et al. Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. J Clin Oncol 2005;23:7143-51.
42. Stevens MC, Rey A, Bouvet N et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 2005;23:2618-28. (Pubitemid 46179450)
43. Strege RJ, Kovacs G, Meyer JE et al. Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children. Strahlenther Onkol 2009;185:789-98.
44. Thomson AB, Critchley HO, Kelnar CJ et al. Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. Best Pract Res Clin Endocrinol Metab 2002;16:311-34.
45. Timmermann B, Schuck A, Niggli F et al. ["Spot-scanning" proton therapy for rhabdomyosarcomas of early childhood. First experiences at PSI]. Strahlenther Onkol 2006;182:653-9. (Pubitemid 44657652)
46. Wang C, Nakayama H, Sugahara S et al. Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer. Strahlenther Onkol 2009;185:231-4.
47. Willich N, Ernst I, Pape H et al. Evaluation of side effects after radiotherapy in childhood and adolescence: from retrospective case reports to a prospective, multicentric and transnational approach. Strahlenther Onkol 2009;185:3-4.